|
Follicular Lymphoma Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 114 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Follicular Lymphoma Global Clinical Trials Review, H1, 2012" provides data on the Follicular Lymphoma clinical trial scenario. This report provides e.....
Introduction GlobalData's clinical trial report, “Follicular Lymphoma Global Clinical Trials Review, H1, 2012" provides data on the Follicular Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Follicular Lymphoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Follicular Lymphoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 7 Introduction 8 Follicular Lymphoma 8 Report Guidance 8 Clinical Trials by Region 9 Clinical Trials by Country 10 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12 Top Five Countries Contributing to Clinical Trials in Europe 13 Top Countries Contributing to Clinical Trials in North America 14 Top Countries Contributing to Clinical Trials in Middle East and Africa 15 Top Five Countries Contributing to Clinical Trials in Central and South America 16 Clinical Trials by BRIC Nations 17 Clinical Trials by G7 Nations 18 Clinical Trials in G7 Nations by Trial Status 19 Clinical Trials by E7 Nations 20 Clinical Trials in E7 Nations by Trial Status 21 Clinical Trials by Phase 22 In Progress Trials by Phase 23 Clinical Trials by Trial Status 24 Unaccomplished Trials of Follicular Lymphoma 25 Subjects Recruited Over a Period of Time 28 Prominent Sponsors 29 Top Companies Participating in Follicular Lymphoma Therapeutics Clinical Trials 31 Prominent Drug Comparison 33 Clinical Trial Profiles 34 Clinical Trial Overview of Top Companies 34 F. Hoffmann-La Roche Ltd. 34 Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 34 GlaxoSmithKline plc 35 Clinical Trial Overview of GlaxoSmithKline plc 35 Millennium Pharmaceuticals, Inc. 36 Clinical Trial Overview of Millennium Pharmaceuticals, Inc. 36 Takeda Pharmaceutical Company Limited 37 Clinical Trial Overview of Takeda Pharmaceutical Company Limited 37 Spectrum Pharmaceuticals, Inc. 38 Clinical Trial Overview of Spectrum Pharmaceuticals, Inc. 38 Eli Lilly and Company 39 Clinical Trial Overview of Eli Lilly and Company 39 Merck & Co., Inc. 40 Clinical Trial Overview of Merck & Co., Inc. 40 Gilead Sciences, Inc. 41 Clinical Trial Overview of Gilead Sciences, Inc. 41 Pfizer Inc. 42 Clinical Trial Overview of Pfizer Inc. 42 Novartis AG 43 Clinical Trial Overview of Novartis AG 43 Celgene Corporation 44 Clinical Trial Overview of Celgene Corporation 44 SymBio Pharmaceuticals Limited 45 Clinical Trial Overview of SymBio Pharmaceuticals Limited 45 Pharmacyclics, Inc. 46 Clinical Trial Overview of Pharmacyclics, Inc. 46 MethylGene Inc 47 Clinical Trial Overview of MethylGene Inc 47 IMMUNOMEDICS, INC 48 Clinical Trial Overview of IMMUNOMEDICS, INC 48 Genitope Corporation 49 Clinical Trial Overview of Genitope Corporation 49 Bayer AG 50 Clinical Trial Overview of Bayer AG 50 Sandoz Inc. 51 Clinical Trial Overview of Sandoz Inc. 51 Cell Therapeutics, Inc. 52 Clinical Trial Overview of Cell Therapeutics, Inc. 52 Seattle Genetics, Inc. 53 Clinical Trial Overview of Seattle Genetics, Inc. 53 Clinical Trial Overview of Top Universities / Institutes / Hospitals 54 Fred Hutchinson Cancer Research Center 54 Clinical Trial Overview of Fred Hutchinson Cancer Research Center 54 The University of Texas M. D. Anderson Cancer Center 56 Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 56 Mayo Clinic 57 Clinical Trial Overview of Mayo Clinic 57 Southwest Oncology Group 58 Clinical Trial Overview of Southwest Oncology Group 58 Groupe d'Etudes de Lymphomes de L'Adulte 59 Clinical Trial Overview of Groupe d'Etudes de Lymphomes de L'Adulte 59 Groupe d Etude des Lymphomes de l Adulte 60 Clinical Trial Overview of Groupe d Etude des Lymphomes de l Adulte 60 Case Comprehensive Cancer Center 61 Clinical Trial Overview of Case Comprehensive Cancer Center 61 Memorial Sloan Kettering Cancer Center 62 Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 62 Massachusetts General Hospital 63 Clinical Trial Overview of Massachusetts General Hospital 63 University of Pennsylvania 64 Clinical Trial Overview of University of Pennsylvania 64 Wake Forest University 65 Clinical Trial Overview of Wake Forest University 65 Instituto Cientifico y Tecnologico de Navarra 66 Clinical Trial Overview of Instituto Cientifico y Tecnologico de Navarra 66 Sarah Cannon Research Institute 67 Clinical Trial Overview of Sarah Cannon Research Institute 67 Swiss Group for Clinical Cancer Research 68 Clinical Trial Overview of Swiss Group for Clinical Cancer Research 68 Ohio State University Comprehensive Cancer Center 69 Clinical Trial Overview of Ohio State University Comprehensive Cancer Center 69 City of Hope National Medical Center 70 Clinical Trial Overview of City of Hope National Medical Center 70 Stanford University 71 Clinical Trial Overview of Stanford University 71 H. Lee Moffitt Cancer Center & Research Institute 72 Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 72 VU University Medical Center 73 Clinical Trial Overview of VU University Medical Center 73 Samsung Medical Center 74 Clinical Trial Overview of Samsung Medical Center 74 Five Key Clinical Profiles 75 Appendix 111 Abbreviations 111 Definitions 111 Research Methodology 112 Secondary Research 112 About GlobalData 113 Contact Us 113 Disclaimer 113 Source 114 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Follicular Lymphoma Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9 Follicular Lymphoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10 Follicular Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11 Follicular Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12 Follicular Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13 Follicular Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2012* 14 Follicular Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15 Follicular Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16 Follicular Lymphoma Therapeutics Clinical Trials, BRIC Countries, 2012* 17 Follicular Lymphoma Therapeutics Clinical Trials, G7 Countries, 2012* 18 Follicular Lymphoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19 Follicular Lymphoma Therapeutics Clinical Trials, E7 Countries, 2012* 20 Follicular Lymphoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21 Follicular Lymphoma Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22 Follicular Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23 Follicular Lymphoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24 Follicular Lymphoma Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25 Follicular Lymphoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26 Follicular Lymphoma Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27 Follicular Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 28 Follicular Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 30 Follicular Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 32 Follicular Lymphoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 33 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 34 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 35 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Millennium Pharmaceuticals, Inc., 2012* 36 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2012* 37 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Spectrum Pharmaceuticals, Inc., 2012* 38 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 39 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 40 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2012* 41 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 42 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 43 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012* 44 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by SymBio Pharmaceuticals Limited, 2012* 45 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2012* 46 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by MethylGene Inc, 2012* 47 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by IMMUNOMEDICS, INC, 2012* 48 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Genitope Corporation, 2012* 49 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 50 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sandoz Inc., 2012* 51 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cell Therapeutics, Inc., 2012* 52 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Genetics, Inc., 2012* 53 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 54 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 56 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 57 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2012* 58 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe d'Etudes de Lymphomes de L'Adulte, 2012* 59 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe d Etude des Lymphomes de l Adulte, 2012* 60 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 61 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 62 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 63 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2012* 64 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012* 65 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto Cientifico y Tecnologico de Navarra, 2012* 66 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2012* 67 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Swiss Group for Clinical Cancer Research, 2012* 68 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2012* 69 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012* 70 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 71 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012* 72 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2012* 73 Follicular Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2012* 74 List of Figures Follicular Lymphoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9 Follicular Lymphoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10 Follicular Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11 Follicular Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12 Follicular Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13 Follicular Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14 Follicular Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 15 Follicular Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16 Follicular Lymphoma Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17 Follicular Lymphoma Therapeutics Clinical Trials, G7 Countries (%), 2012* 18 Follicular Lymphoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19 Follicular Lymphoma Therapeutics Clinical Trials, E7 Countries (%), 2012* 20 Follicular Lymphoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21 Follicular Lymphoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22 Follicular Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23 Follicular Lymphoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24 Follicular Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 28 Follicular Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29 Follicular Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31 Follicular Lymphoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 33 GlobalData Methodology 112 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
